Woodson Jesse D, Zayas Carmen L, Escalante-Semerena Jorge C
Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin 53726, USA.
J Bacteriol. 2003 Dec;185(24):7193-201. doi: 10.1128/JB.185.24.7193-7201.2003.
The ability of archaea to salvage cobinamide has been under question because archaeal genomes lack orthologs to the bacterial nucleoside triphosphate:5'-deoxycobinamide kinase enzyme (cobU in Salmonella enterica). The latter activity is required for cobinamide salvaging in bacteria. This paper reports evidence that archaea salvage cobinamide from the environment by using a pathway different from the one used by bacteria. These studies demanded the functional characterization of two genes whose putative function had been annotated based solely on their homology to the bacterial genes encoding adenosylcobyric acid and adenosylcobinamide-phosphate synthases (cbiP and cbiB, respectively) of S. enterica. A cbiP mutant strain of the archaeon Halobacterium sp. strain NRC-1 was auxotrophic for adenosylcobyric acid, a known intermediate of the de novo cobamide biosynthesis pathway, but efficiently salvaged cobinamide from the environment, suggesting the existence of a salvaging pathway in this archaeon. A cbiB mutant strain of Halobacterium was auxotrophic for adenosylcobinamide-GDP, a known de novo intermediate, and did not salvage cobinamide. The results of the nutritional analyses of the cbiP and cbiB mutants suggested that the entry point for cobinamide salvaging is adenosylcobyric acid. The data are consistent with a salvaging pathway for cobinamide in which an amidohydrolase enzyme cleaves off the aminopropanol moiety of adenosylcobinamide to yield adenosylcobyric acid, which is converted by the adenosylcobinamide-phosphate synthase enzyme to adenosylcobinamide-phosphate, a known intermediate of the de novo biosynthetic pathway. The existence of an adenosylcobinamide amidohydrolase enzyme would explain the lack of an adenosylcobinamide kinase in archaea.
古菌挽救钴胺酰胺的能力一直受到质疑,因为古菌基因组缺乏与细菌核苷三磷酸:5'-脱氧钴胺酰胺激酶(肠炎沙门氏菌中的cobU)直系同源的基因。后者的活性是细菌中钴胺酰胺挽救所必需的。本文报道了证据表明古菌通过使用与细菌不同的途径从环境中挽救钴胺酰胺。这些研究需要对两个基因进行功能表征,其假定功能仅基于它们与编码肠炎沙门氏菌腺苷钴胺酸和腺苷钴胺酰胺 - 磷酸合酶(分别为cbiP和cbiB)的细菌基因的同源性进行注释。古菌嗜盐菌属菌株NRC - 1的cbiP突变株对腺苷钴胺酸营养缺陷,腺苷钴胺酸是从头合成钴胺酰胺生物合成途径的已知中间体,但能有效地从环境中挽救钴胺酰胺,这表明该古菌中存在挽救途径。嗜盐菌的cbiB突变株对腺苷钴胺酰胺 - GDP营养缺陷,腺苷钴胺酰胺 - GDP是已知的从头合成中间体,并且不能挽救钴胺酰胺。cbiP和cbiB突变体的营养分析结果表明,钴胺酰胺挽救的切入点是腺苷钴胺酸。数据与钴胺酰胺的挽救途径一致,其中酰胺水解酶切除腺苷钴胺酰胺的氨基丙醇部分以产生腺苷钴胺酸,腺苷钴胺酸由腺苷钴胺酰胺 - 磷酸合酶转化为腺苷钴胺酰胺 - 磷酸,这是从头生物合成途径的已知中间体。腺苷钴胺酰胺酰胺水解酶的存在将解释古菌中缺乏腺苷钴胺酰胺激酶的现象。